Position in HAE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$505,661
-$969,211 QoQ
Shares Held
8,972
-70.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HAE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Freestone Grove Partners LP holds $115,057,650 across 10 Medical Devices names. HAE ranks #4 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
226,560 | $47,541,350 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
147,605 | $41,144,893 | |
| 3 | TNDM |
Tandem Diabetes Care Inc
|
1,330,742 | $25,510,324 | |
| 4 | HAE |
Haemonetics Corp
This page
|
8,972 | $505,661 | |
| 5 | SYK |
Stryker Corp
|
493 | $161,994 | |
| 6 | INSP |
Inspire Medical Systems, Inc.
|
3,021 | $155,823 | |
| 7 | CNMD |
CONMED Corp
|
1,027 | $36,314 | |
| 8 | MASI |
Masimo Corp
|
7 | $1,245 |
All Filings in HAE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $505,661 | 8,972 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,474,872 | 30,260 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||